Debiopharm Innovation Fund Overview

  • Investor Type
  • Venture Capital

  • Status
  • Active

  • Professionals
  • 6


  • Investments
  • 42

  • Portfolio
  • 22

  • Exits
  • 12


Debiopharm Innovation Fund General Information

Company Description

Founded in 2008, Debiopharm Innovation Fund is the corporate venture capital arm of Debiopharm Group based in Lausanne, Switzerland. The firm seeks to invest in companies developing smart data technologies applied to drug development and the digitalization of patients.

Business Details

Year Founded
Investor Status
Actively Seeking New Investments
Primary Investor Type
Corporate Venture Capital
Corporate Office
  • Chemin Messidor 5-7
  • Case postale 435
  • 1001 Lausanne
  • Switzerland
+41 021 000 00 00

Debiopharm Innovation Fund Investments & Acquisitions (42)

Company Name Deal Date Deal Type Deal Size Industry Company Stage Lead Partner
Nucleai 03-Apr-2024 Later Stage VC 0000 Decision/Risk Analysis Generating Revenue
OmicsChart 01-Nov-2023 00000 00000 Media and Information Services (B2B) Generating Revenue
Strategikon 04-Oct-2023 00000 00000 000 Enterprise Systems (Healthcare) Generating Revenue
Neuroute 28-Sep-2023 0000 00000 Other Healthcare Technology Systems Generating Revenue 0000 00000 00
Tune Insight 27-Sep-2023 0000 00000 00.00 Network Management Software Generating Revenue
Altis Labs 21-Jun-2023 0000 00000 000 Decision/Risk Analysis Generating Revenue 0000000 0000000
Concr 05-May-2023 0000 00000 00.000 Biotechnology Generating Revenue
Iktos 09-Mar-2023 00000 00000 000.00 Biotechnology Generating Revenue 00000 0000
Genialis 19-Jan-2023 Later Stage VC 0000 Drug Discovery Generating Revenue 000000 00000-0000
MedaSystems 09-Jan-2023 Seed Round Enterprise Systems (Healthcare) Generating Revenue 0000000 0000000
You’re viewing 10 of 42 investments and acquisitions. Get the full list »

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Debiopharm Innovation Fund Exits (12)

Company Name Exit Date Exit Type Exit Size
OnComfort 04-Oct-2023 Merger/Acquisition
Voluntis 01-Nov-2021 000000000000000000 000.00
Kaiku Health 15-May-2020 000000000000000000 000.00
ABAC Therapeutics 30-Oct-2019 0000000000
GenePOC 03-Jun-2019 000000000000000000 00000
Spinomix 01-Apr-2018 000 00 00000000
OSE Immunotherapeutics 26-Jan-2017 000000000 00000000 000.00
Effimune 24-Feb-2016 000000000000000000 000.00
Biocartis 27-Apr-2015 IPO 00000
Diagnoplex 12-Feb-2015 Merger/Acquisition
You’re viewing 10 of 12 exits. Get the full list »

Debiopharm Innovation Fund Investments by Industry, Year, and Region

Investments by Industry

Investments by Year

Investments by Region

PitchBook’s data visualizations quickly surface an investor’s historical investments—showing a breakdown of activity by industry, year and region.

Request a free trial

Debiopharm Innovation Fund Management, Team & Partners (10)

Name Title Deals Funds Boards Office
Vincent Lepreux Investment Principal 0 0 Lausanne, Switzerland
Edward Jensen Global Program Leader Lausanne, Switzerland
Nicolas Stalder Senior Investment Associate Lausanne, Switzerland
Thomas Gibbs Ph.D Senior Investment Director 0 0 Lausanne, Switzerland
Cedric Odje Investment Associate 0 0 Lausanne, Switzerland
You’re viewing 5 of 10 team members. Get the full list »

Debiopharm Innovation Fund Co-Investors (69)

Name With Exits Lead Partner Series Industry
M Ventures 2 0 Series chart Industry bar
Omnes Capital 0 0 Series chart Industry bar
S32 0 0 Series chart Industry bar
Magnetar Capital 0 0 Series chart Industry bar
Oxford Technology Management 0 0 Series chart Industry bar
You’re viewing 5 of 69 co-investors. Get the full list »

Debiopharm Innovation Fund FAQs

  • What is Debiopharm Innovation Fund?

    Founded in 2008, Debiopharm Innovation Fund is the corporate venture capital arm of Debiopharm Group based in Lausanne, Switzerland.

  • When was Debiopharm Innovation Fund founded?

    Debiopharm Innovation Fund was founded in 2008.

  • Where is Debiopharm Innovation Fund headquartered?

    Debiopharm Innovation Fund is headquartered in Lausanne, Switzerland.

  • What is Debiopharm Innovation Fund's total asset value?

    Debiopharm Innovation Fund has around 00000 in total assets under management.

  • How many investments has Debiopharm Innovation Fund made?

    Debiopharm Innovation Fund has made 42 investments.

  • What has Debiopharm Innovation Fund invested in?

    Debiopharm Innovation Fund has made numerous investments in companies like Nucleai, OmicsChart, and Strategikon within the Decision/Risk Analysis, Media and Information Services (B2B), and Enterprise Systems (Healthcare) industries.

  • What has Debiopharm Innovation Fund invested in recently?

    Debiopharm Innovation Fund's latest investment was on 03-Apr-2024 in Nucleai, a company within the Decision/Risk Analysis industry.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »